Jonathan Zalevsky
Senior Vice President
Biology and Preclinical Development
Nektar Therapeutics
United States of America
Biography
Dr. Zalevsky has over 13 years of experience spanning both large pharmaceutical and small biotechnology companies to Nektar. he authored numerous high-profile publications on Xencor-discovered drugs and wrote four INDs.
Research Interest
Biochemistry and Molecular, Cellular and Developmental Biology
